High-gain photonic crystal fiber regenerative amplifier.

Opt Lett

NIF and Photon Science Directorate, Lawrence Livermore National Laboratory, Livermore, CA 94551, USA.

Published: March 2009

We have demonstrated a photonic crystal fiber-based regenerative amplifier at 1.078 microm. The input signal pulse energy is 20 pJ in a 12 ns pulse at a 3 kHz repetition rate. At 8.6 W of input pump power, the amplified output pulse energy is 157 microJ, yielding a gain of 69 dB. To our knowledge, this is the highest gain achieved in a fiber-based regenerative amplifier to date at any wavelength.

Download full-text PDF

Source
http://dx.doi.org/10.1364/ol.34.000608DOI Listing

Publication Analysis

Top Keywords

regenerative amplifier
12
photonic crystal
8
fiber-based regenerative
8
pulse energy
8
high-gain photonic
4
crystal fiber
4
fiber regenerative
4
amplifier demonstrated
4
demonstrated photonic
4
crystal fiber-based
4

Similar Publications

CD4-Derived Double-Negative T Cells Ameliorate Alzheimer's Disease-Like Phenotypes in the 5×FAD Mouse Model.

CNS Neurosci Ther

January 2025

State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.

Background: Alzheimer's disease (AD) is a debilitating neurodegenerative disorder that is difficult to predict and is typically diagnosed only after symptoms manifest. Recently, CD4 T cell-derived double-negative T (DNT) cells have shown strong immuno-regulatory properties in both in vitro and in vivo neuronal inflammation studies. However, the effectiveness of DNT cells in treating on AD are not yet fully understood.

View Article and Find Full Text PDF

Insights into the ecological and climate crisis: emerging infections threatening human health.

Acta Trop

January 2025

Clinic of Infectious Diseases, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari "Aldo Moro", 70124 Bari, Italy.

The Anthropocene era is marked by unprecedented human-induced alterations to the environment, resulting in a climate emergency and widespread ecological deterioration. A staggering number of up to one million species of plants and animals are in danger of becoming extinct, which includes over 10% of insect species and 40% of plant species. Unrestrained release of greenhouse gases, widespread deforestation, intense agricultural practices, excessive fishing, and alterations in land use have exceeded the ecological boundaries that were once responsible for humanity's wellbeing.

View Article and Find Full Text PDF

Merkel cell carcinoma (MCC) is a rare but aggressive neuroendocrine skin cancer with limited treatment options, often associated with Merkel cell polyomavirus (MCPyV) and marked by hypoxic tumor microenvironments that promote resistance to therapies. Belzutifan, an FDA-approved hypoxia-inducible factor-2α (HIF-2α) inhibitor, has shown promise in inhibiting tumor growth; however, its clinical efficacy is hindered by its low solubility, rapid clearance, and limited bioavailability. In this study, we present a strategy using porous silicon (pSi) microparticles and nanoparticles as carriers for the sustained delivery of benzoate to MCC cells.

View Article and Find Full Text PDF

Macrophages encounter a myriad of biochemical and mechanical stimuli across various tissues and pathological contexts. Notably, matrix rigidity has emerged as a pivotal regulator of macrophage activation through mechanotransduction. However, the precise mechanisms underlying the interplay between mechanical and biochemical cues within the nuclear milieu remain elusive.

View Article and Find Full Text PDF

Osteosarcoma (OS) is the most common primary bone malignancy. The canonical Wnt inhibitor Dickkopf-1 (Dkk-1) has been implicated in bone destruction, tumor survival and metastases during OS. We examined the role of Dkk-1 in OS disease progression and explored strategies for targeting its activity.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!